The duration of dual antiplatelet therapy (DAPT) should be individualized based on ischaemic and bleeding risk of a particular patient, rather than focusing on a dualistic short- vs long-duration therapy thinking, advocates a leading expert during AFCC 2018.
The burden of heart failure (HF) in Asia is high compared with the US and Europe, with Southeast Asia (SEA) having the highest HF prevalence vs other Asian regions combined, and the youngest patients having the worst outcomes, according to data presented at AFCC 2018.
Mitral valve (MV) repair appears to be associated with a lower mortality rate and better clinical outcomes in patients with infective endocarditis compared with MV replacement, according to review of previous studies presented at AFCC 2018.
Treatment with the nonselective aldosterone receptor agonist spironolactone can significantly reduce ventricular arrhythmic events in patients with implantable cardioverter defibrillator (ICD), according to a Thailand study presented at the 23rd ASEAN Federation of Cardiology Congress (AFCC 2018).
The lower threshold for hypertension diagnosis in the 2017 ACC/AHA hypertension guidelines does not necessarily entail more pharmacological treatment, says a leading expert in cardiology during a presentation at AFCC 2018, who highlights that the first key step for managing hypertension is lifestyle modification.
Episodes of ventricular tachycardia/ventricular fibrillation (VT/VF) in patients with Brugada syndrome can be predicted by electrocardiogram (ECG) findings at the time of implantable cardioverter-defibrillator (ICD) placement including T-peak to T-end interval, according to a study presented at the 23rd ASEAN Federation of Cardiology Congress (AFCC) held in Bangkok, Thailand.
Despite being an uncommon complication of coronary artery bypass surgery (CABG), postoperative ventricular arrhythmia (POVA) increases the risk of in-hospital mortality and poor long-term prognosis, according to a recent poster presented at the recently concluded 23rd ASEAN Federation of Cardiology Congress (AFCC 2018), in Bangkok, Thailand.
Among patients who have received coronary artery bypass grafting (CABG), postoperative renal injury and failure as defined by the RIFLE criteria are only seen in the group of patients categorized as low risk of acute kidney injury (AKI) by the THAKAR score, according to a study presented at the 23rd ASEAN Federation of Cardiology Congress (AFCC 2018) in Bangkok, Thailand.
The efficacy and cardiovascular (CV) safety of the SGLT2* inhibitor empagliflozin vs DPP-4** inhibitors and GLP-1*** receptor agonists in real-world patients were demonstrated in two interim analyses of the EMPRISE+ study presented at ADA 2020.
Patients hospitalized with mild-to-moderate COVID-19 who are on angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for hypertension should continue these medications, according to primary results of the BRACE CORONA trial presented at ESC 2020.
Anticoagulation therapy may be of value to patients with new-onset atrial fibrillation (AF) associated with sepsis, easing the risk of all-cause mortality and ischaemic stroke without increasing the likelihood of major bleeding, reports a study presented at the Digital 2020 Congress of the European Society of Cardiology (ESC).